-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
PKF050-638
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/528893-52-9.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 528893-52-9 |
| Description | PKF050-638 is a potent and selective inhibitor of HIV-1 Rev (IC50=0.04 μM). PKF050-638 inhibits the CRM1-mediated Rev nuclear export by disrupting CRM1-NES interaction. |
Product Information
| Synonyms | PKF050-638|528893-52-9|(2Z)-3-[5-(2-Amino-5-chlorophenyl)-1H-1,2,4-triazol-1-yl]-2-propenoic acid ethyl ester|SCHEMBL12127035|ethyl (Z)-3-[5-(2-amino-5-chlorophenyl)-1,2,4-triazol-1-yl]prop-2-enoate|HY-114597|CS-0063505|ethyl (Z)-3-[5-(2-amino-5-chloro-phenyl)-1,2,4-triazol-1-yl]prop-2-enoate|2-Propenoic acid, 3-[5-(2-amino-5-chlorophenyl)-1H-1,2,4-triazol-1-yl]-, ethyl ester, (2Z)- |
| Molecular Weight | 292.72 |
| Molecular Formula | C13H13ClN4O2 |
| Canonical SMILES | CCOC(=O)C=CN1C(=NC=N1)C2=C(C=CC(=C2)Cl)N |
| Purity | ≥98% (HPLC) |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 366 |
| Exact Mass | 292.0727034 |
| In Vitro | Nuclear export of Rev is mediated by its leucine-rich nuclear export signal (NES) and is known to use the CRM1 export factor to export the viral RNA from the nucleus to the cytoplasm. CRM1 is a nuclear export receptor for proteins carrying the leucine-rich NES. PKF050-638 (5 μM; 2 hours) inhibits nuclear export of rev, in addition, the Rev14-GFP mutant accumulates in the nucleus indicating that the NES of Rev is a part of Rev required for export inhibition by PKF050-638. PKF050-638 (7.5 μM; 4 hours) restores the inhibition of export in pRev14-GFP-transfected cells. In cells incubated with PKF050-638, most of the Rev14-GFP is localized in the nucleus and nucleolus. Whereas in untreated cells, Rev14-GFP is still in the cytoplasm. This result shows that the majority of PKF050-638-treated cells are able to reverse completely the inhibitory effects of the agent. PKF050-638 (7.5 μM; 1 hour) is interfering with the CRM1-mediated nuclear export machinery. HeLa cells are cotransfected with the BFP-tagged Rev protein and the GFP-tagged hCRM1. Upon treatment with PKF050-638, this Rev-dependent hCRM1 nucleolar localization is abolished after 60 min, and PKF050-638 does not affect the Rev nucleolar distribution. |
| Target | IC50: 0.04 μM (HIV-1 Rev) |
| XLogP3-AA | 2.1 |